Companies have long lamented Europe's fragmented capital markets, single-market adoption on pricing and clinical trials, and uneven reimbursement policies.

BUSINESS
Founder of China's Evergrande pleads guilty to fraud
Evergrande was once China's biggest real estate firm, with a stock market valuation of more than $50bn.
BBC News·2h ago

